Benefits of Wheatgrass

Evidence-Based Benefits

• Antioxidant activity — wheatgrass contains high concentrations of chlorophyll, flavonoids, and phenolic compounds that scavenge free radicals and reduce oxidative stress markers in vitro and in small human trials (Bar-Sela et al., 2007)
• Anemia and thalassemia support — a pilot study by Marwaha et al. (2004) in transfusion-dependent beta-thalassemia patients found wheatgrass juice reduced the mean interval between transfusions, suggesting hemoglobin-supporting properties potentially linked to its chlorophyll content
• Ulcerative colitis — Ben-Arye et al. (2002) conducted a randomized double-blind trial showing wheatgrass juice significantly reduced rectal bleeding severity and disease activity index in patients with active distal ulcerative colitis
• Blood sugar regulation — Shakya et al. (2016) found wheatgrass supplementation improved fasting glucose and lipid profiles in type 2 diabetic subjects in a small controlled trial
• Nutrient density — per gram, wheatgrass provides concentrated amounts of iron, magnesium, calcium, vitamins A, C, and E, and all essential amino acids, making it a micronutrient-dense green supplement

What the Research Says

Wheatgrass research is still in its early stages, with several small but notable clinical trials contributing to the body of evidence. A pivotal study by Ben-Arye et al. (2002) demonstrated that 100ml daily wheatgrass juice significantly reduced rectal bleeding and disease activity in patients with active distal ulcerative colitis over one month. In hematology, Marwaha et al. (2004) reported that wheatgrass juice extended the interval between blood transfusions in beta-thalassemia patients, though the mechanism remains speculative. Bar-Sela et al. (2007) observed a reduction in chemotherapy-related myelotoxicity in breast cancer patients consuming wheatgrass juice, though this was an observational study.

More recent studies have expanded on these findings. Shakya et al. (2016) found that wheatgrass improved fasting glucose and lipid parameters in type 2 diabetes patients. Additionally, Mutha et al. (2018) conducted a randomized study of 69 thalassemic children, showing that wheatgrass supplementation over 18 months improved quality of life and reduced liver and spleen size compared to controls. Kumar and Iyer (2017) demonstrated that wheatgrass supplementation reduced total cholesterol, triacylglycerols, and Apolipoprotein B in hyperlipidemic women.

Despite these promising results, the majority of studies suffer from small sample sizes (typically under 50 participants) and variability in wheatgrass preparations (fresh juice vs. powder). A systematic review by Langhorst et al. (2015) highlighted the need for larger, well-designed randomized controlled trials to confirm these preliminary findings and establish definitive efficacy.

Related Conditions